Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIR
2526
DELISTED
CIRCOR International, Inc
CIR
| $5.57M | ﹤0.01% |
98,759
-236,385
| -71% | -$8.28M |
|
2527
Texas Pacific Land
TPL
$25.5B
| $5.57M | ﹤0.01% |
+38,088
| New | +$6.11M |
|
2528
Sasol
SSL
$7.44B
| $5.56M | ﹤0.01% |
449,202
-324,105
| -42% | -$4.17M |
|
2529
Kforce
KFRC
$1.04B
| $5.56M | ﹤0.01% |
88,727
+82,944
| +1,434% | +$5M |
|
2530
CALL
Hershey
HSY
$36.4B
| $5.54M | ﹤0.01% |
22,200
+6,000
| +37% | +$1.57M |
|
2531
Hingham Institution for Saving
HIFS
$655M
| $5.53M | ﹤0.01% |
25,963
+17,465
| +206% | +$3.56M |
|
2532
Merck
MRK
$369B
| $5.52M | ﹤0.01% |
47,861
+10,410
| +28% | +$1.18M |
|
2533
Privia Health
PRVA
$2.66B
| $5.52M | ﹤0.01% |
211,309
-296,973
| -58% | -$7.84M |
|
2534
Texas Instruments
TXN
$243B
| $5.52M | ﹤0.01% |
30,637
-83,943
| -73% | -$14.5M |
|
2535
Acumen Pharmaceuticals
ABOS
$219M
| $5.51M | ﹤0.01% |
1,146,018
+500,135
| +77% | +$2.39M |
|
2536
Ceco Environmental
CECO
$4.23B
| $5.51M | ﹤0.01% |
412,579
-508,646
| -55% | -$6.32M |
|
2537
CALL
iShares Silver Trust
SLV
$33.8B
| $5.51M | ﹤0.01% |
263,700
-4,176,400
| -94% | -$92.8M |
|
2538
PUT
Best Buy
BBY
$17.6B
| $5.51M | ﹤0.01% |
67,200
+10,400
| +18% | +$777K |
|
|
AAN
2539
DELISTED
The Aaron's Company Inc
AAN
| $5.5M | ﹤0.01% |
388,749
+84,267
| +28% | +$1.04M |
|
2540
Danaos Corp
DAC
$2.75B
| $5.49M | ﹤0.01% |
82,181
-167,518
| -67% | -$10.1M |
|
2541
HighPeak Energy
HPK
$1.01B
| $5.48M | ﹤0.01% |
+504,057
| New | +$8.49M |
|
2542
NBT Bancorp
NBTB
$2.67B
| $5.48M | ﹤0.01% |
172,170
+138,646
| +414% | +$4.64M |
|
|
EGRX
2543
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.48M | ﹤0.01% |
281,745
-15,721
| -5% | -$373K |
|
2544
Descartes Systems
DSGX
$6.91B
| $5.46M | ﹤0.01% |
68,211
+57,197
| +519% | +$4.46M |
|
2545
PUT
Omnicom Group
OMC
$24.1B
| $5.46M | ﹤0.01% |
57,400
+50,400
| +720% | +$4.68M |
|
2546
Vanguard Morningstar Value ETF
VTV
$193B
| $5.46M | ﹤0.01% |
38,412
-117,825
| -75% | -$16.4M |
|
2547
CALL
Kroger
KR
$34.9B
| $5.46M | ﹤0.01% |
116,100
+2,400
| +2% | +$114K |
|
2548
Vanguard Total World Stock ETF
VT
$81.5B
| $5.46M | ﹤0.01% |
56,256
+16,435
| +41% | +$1.54M |
|
2549
CALL
Raymond James Financial
RJF
$33.9B
| $5.45M | ﹤0.01% |
52,500
+13,500
| +35% | +$1.25M |
|
2550
Universal Corp
UVV
$1.14B
| $5.44M | ﹤0.01% |
109,013
+41,873
| +62% | +$2.2M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.